Researchers at the University of Houston have developed a new nasal vaccine called NanoSTING-SN to prevent transmission of COVID-19 and other coronaviruses. Additionally, they created NanoSTING, an immune activator that has successfully passed the animal testing phase and shows promise as a complementary treatment for fighting strains of COVID-19. This innovative approach could enhance the body’s immune response to various respiratory viruses.
Sources:
https://www.uh.edu/news-events/stories/2024/august/08062024-varadarajan-nanosting-rx-and-vaccine.php
https://www.egr.uh.edu/news/202408/university-houston-researchers-create-new-treatment-and-vaccine-flu-and-various-0
See also CDC can't substantiate COVID vaccine ingredient claims, FDA forced to turn over Pfizer data